(Total Views: 598)
Posted On: 10/20/2020 2:35:51 PM
Post# of 153903
Quote:@CDiddy
Clearly. Blafarm, seems like you are trying awefully hard this time to find things to nitpick. Guess that means Nader is improving.
Is it really too much to ask for a clearly worded PR that doesn't take the members of this board days to unpack? Because that's what we've been doing for months now -- trying to decipher the meaning and ramifications of poorly drafted PRs. I will resist the temptation to discuss conference call issues, as it is an entirely unproductive line of thought.
I am not a mindless cheerleader, and I don't subscribe to the flavor of blind optimism that had some members here fanatically believing that today's outcome was going to include all manner of approvals.
I say, live and let live. However, I am weary of my objective and analytical nature being misconstrued and distorted to imply that I am a short and a basher. There is no short or basher in the world that has spent this much time and invested this much money in a stock they were trying to hammer.
Lastly, I will say that I firmly believe today's outcome was excellent. We are in the pipe, five by five. The 293 interim is designed to succeed and it has largely de-risked this investment and CytoDyn's ability to fund future indications.
I can't wait for the readout.
(14)
(0)
